Kozlowska et al. (15) show that GBM stem cells are highly susceptible to NK-mediated killing, but after differentiation of these stem cells, anergic NK cells fail to control GBM tumor growth because of the release of IL-6 and IL-8. This evidence concerns the gene CXCL8 and glioblastoma.